FDA extends PDUFA date for Eton's ET-400 NDA to May 28, 2025

Eton Pharmaceuticals, Inc.

Original PDUFA date Feb 28, 2025 extended 3 months to May 28, 2025 for FDA review of supplemental info submitted Dec 2024.
Eton states it has fully addressed all FDA questions and there are no outstanding requests.
CEO says standard extension will not significantly affect internal 2025 revenue projections; company remains confident.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.